Hallek M
Am J Hematol. 2025; 100(3):450-480.
PMID: 39871707
PMC: 11803567.
DOI: 10.1002/ajh.27546.
Taha S, Karimi M, Mahdavi B, Yousefi Tehrani M, Bemani A, Kabirian S
Epigenetics Chromatin. 2025; 18(1):3.
PMID: 39810224
PMC: 11734566.
DOI: 10.1186/s13072-024-00560-8.
Shabani M, Rostamzadeh D, Mansouri M, Jeddi-Tehrani M
Avicenna J Med Biotechnol. 2024; 16(4):201-222.
PMID: 39606680
PMC: 11589431.
DOI: 10.18502/ajmb.v16i4.16737.
Zhang R, Khare P, Banerjee P, Ivan C, Schneider S, Barbaglio F
Blood Cancer J. 2024; 14(1):168.
PMID: 39438453
PMC: 11496494.
DOI: 10.1038/s41408-024-01142-3.
Weniger M, Seifert M, Kuppers R
Methods Mol Biol. 2024; 2865:1-30.
PMID: 39424718
DOI: 10.1007/978-1-0716-4188-0_1.
Stage-specific modulation of multinucleation, fusion, and resorption by the long non-coding RNA DLEU1 and miR-16 in human primary osteoclasts.
Moura S, Sousa A, Olesen J, Barbosa M, Soe K, Almeida M
Cell Death Dis. 2024; 15(10):741.
PMID: 39389940
PMC: 11467329.
DOI: 10.1038/s41419-024-06983-1.
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.
Nano E, Reggiani F, Amaro A, Monti P, Colombo M, Bertola N
Noncoding RNA. 2024; 10(5).
PMID: 39311383
PMC: 11417859.
DOI: 10.3390/ncrna10050046.
The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications.
Mirandari A, Parker H, Ashton-Key M, Stevens B, Walewska R, Stamatopoulos K
Explor Target Antitumor Ther. 2024; 5(4):877-901.
PMID: 39280243
PMC: 11390296.
DOI: 10.37349/etat.2024.00253.
Loss of microRNA-15a/16-1 function promotes neuropathological and functional recovery in experimental traumatic brain injury.
Zhou C, Li S, Qiu N, Sun P, Hamblin M, Dixon C
JCI Insight. 2024; 9(12).
PMID: 38912585
PMC: 11383186.
DOI: 10.1172/jci.insight.178650.
Mouse models of chronic lymphocytic leukemia and Richter transformation: what we have learnt and what we are missing.
Bertilaccio M, Chen S
Front Immunol. 2024; 15:1376660.
PMID: 38903501
PMC: 11186982.
DOI: 10.3389/fimmu.2024.1376660.
Noncanonical microprotein regulation of immunity.
Nichols C, Do-Thi V, Peltier D
Mol Ther. 2024; 32(9):2905-2929.
PMID: 38734902
PMC: 11403233.
DOI: 10.1016/j.ymthe.2024.05.021.
MNDA, a PYHIN factor involved in transcriptional regulation and apoptosis control in leukocytes.
Bottardi S, Layne T, Ramon A, Quansah N, Wurtele H, Affar E
Front Immunol. 2024; 15:1395035.
PMID: 38680493
PMC: 11045911.
DOI: 10.3389/fimmu.2024.1395035.
MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemia.
Ali A, Mahla S, Reza V, Hossein A, Bahareh K, Mohammad H
EJHaem. 2024; 5(1):191-205.
PMID: 38406506
PMC: 10887358.
DOI: 10.1002/jha2.849.
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma.
Rampioni Vinciguerra G, Capece M, Reggiani Bonetti L, Nigita G, Calore F, Rentsch S
Signal Transduct Target Ther. 2024; 9(1):31.
PMID: 38342897
PMC: 10859382.
DOI: 10.1038/s41392-024-01740-4.
Long noncoding RNA DLEU2 and ROR1 pathway induces epithelial-to-mesenchymal transition and cancer stem cells in breast cancer.
Islam S, Al-Tweigeri T, Al-Harbi L, Ujjahan S, Al-Mozaini M, Tulbah A
Cell Death Discov. 2024; 10(1):61.
PMID: 38296962
PMC: 10830457.
DOI: 10.1038/s41420-024-01829-3.
A lncRNA Dleu2-encoded peptide relieves autoimmunity by facilitating Smad3-mediated Treg induction.
Tang S, Zhang J, Lou F, Zhou H, Cai X, Wang Z
EMBO Rep. 2024; 25(3):1208-1232.
PMID: 38291338
PMC: 10933344.
DOI: 10.1038/s44319-024-00070-4.
Mice Overexpressing Wild-Type Are a Novel Model for Preclinical Testing of Anti-Chronic Lymphocytic Leukemia Therapies.
Hortal A, Villanueva A, Arellano I, Prieto C, Mendoza P, Bustelo X
Cancers (Basel). 2023; 15(24).
PMID: 38136362
PMC: 10742337.
DOI: 10.3390/cancers15245817.
A Glimmer of Hope for Patients with a T3 Transformation Zone: miRNAs Are Potential Biomarkers for Cervical Dysplasia.
Wittenborn J, Flasshove E, Kupec T, Najjari L, Stickeler E, Maurer J
Diagnostics (Basel). 2023; 13(24).
PMID: 38132183
PMC: 10742976.
DOI: 10.3390/diagnostics13243599.
An essential role for miR-15/16 in Treg suppression and restriction of proliferation.
Johansson K, Gagnon J, Zhou S, Fassett M, Schroeder A, Kageyama R
Cell Rep. 2023; 42(10):113298.
PMID: 37862171
PMC: 10664750.
DOI: 10.1016/j.celrep.2023.113298.
Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state.
Ng A, Lovat F, Shih A, Ma Y, Pekarsky Y, DiCaro F
Proc Natl Acad Sci U S A. 2023; 120(43):e2308658120.
PMID: 37844234
PMC: 10614620.
DOI: 10.1073/pnas.2308658120.